Literature DB >> 27561194

Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION).

Kishan S Parikh1, Adrian Coles2, Phillip J Schulte3, William E Kraus4, Jerome L Fleg5, Steven J Keteyian6, Ileana L Piña7, Mona Fiuzat2, David J Whellan8, Christopher M O'Connor9, Robert J Mentz10.   

Abstract

Angina pectoris (AP) is associated with worse outcomes in heart failure (HF). We investigated the association of AP with health-related quality of life (HRQoL), exercise capacity, and clinical outcomes and its interaction with exercise training in an HF population. We grouped 2,331 patients with HF with reduced ejection fraction in the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) trial of usual care ± exercise training according to whether they had self-reported AP by Canadian classification score. HRQoL and clinical outcomes were assessed by AP status. In HF-ACTION, 406 patients (17%) had AP at baseline (44% with Canadian classification score ≥II) with HF severity similar to those without AP. Patients with AP had similar baseline exercise capacity but worse depressive symptoms and HRQoL. AP was associated with 22% greater adjusted risk for all-cause mortality/hospitalizations, driven by hospitalizations. There was significant interaction between baseline AP and exercise training peak VO2 change (p = 0.019) but not other end points. Exercise training was associated with greater peak VO2 improvement after 3 months in patients with AP (treatment effect = 1.25 ml/kg/min, 95% CI 0.6 to 1.9). In conclusion, AP was associated with worse HRQoL and depressive symptoms. Despite greater peak VO2 improvement with exercise training, patients with AP experienced more adverse outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27561194      PMCID: PMC5050169          DOI: 10.1016/j.amjcard.2016.07.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).

Authors:  P Hjemdahl; S V Eriksson; C Held; L Forslund; P Näsman; N Rehnqvist
Journal:  Heart       Date:  2005-06-10       Impact factor: 5.994

2.  Clinical validation of a quality of life questionnaire in angina pectoris patients.

Authors:  P Marquis; C Fayol; J E Joire
Journal:  Eur Heart J       Date:  1995-11       Impact factor: 29.983

3.  A standardized definition of ischemic cardiomyopathy for use in clinical research.

Authors:  G Michael Felker; Linda K Shaw; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  Characteristics of a contemporary population with angina pectoris. TIDES Investigators.

Authors:  C J Pepine; J Abrams; R G Marks; J J Morris; S S Scheidt; E Handberg
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

5.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Authors:  Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Journal:  JAMA       Date:  2009-04-08       Impact factor: 56.272

6.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

7.  Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

Authors:  N Rehnqvist; P Hjemdahl; E Billing; I Björkander; S V Eriksson; L Forslund; C Held; P Näsman; N H Wallén
Journal:  Eur Heart J       Date:  1996-01       Impact factor: 29.983

Review 8.  The burden of angina pectoris and its complications [corrected].

Authors:  Eric Peterson
Journal:  Clin Cardiol       Date:  2007-02       Impact factor: 2.882

9.  Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events.

Authors:  Robert J Mentz; Samuel Broderick; Linda K Shaw; Karen Chiswell; Mona Fiuzat; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2014-06-27       Impact factor: 15.534

Review 10.  Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis.

Authors:  Michael McGillion; Sheila O'Keefe-McCarthy; Sandra L Carroll; J Charles Victor; Tammy Cosman; Allison Cook; John G Hanlon; E Marc Jolicoeur; Noorin Jamal; Robert McKelvie; Heather M Arthur
Journal:  BMC Cardiovasc Disord       Date:  2014-02-01       Impact factor: 2.298

View more
  4 in total

Review 1.  Assessing Prognosis of Acute Coronary Syndrome in Recent Clinical Trials: A Systematic Review.

Authors:  Fan Ye; David Winchester; Michael Jansen; Arthur Lee; Burton Silverstein; Carolyn Stalvey; Matheen Khuddus; Joseph Mazza; Steven Yale
Journal:  Clin Med Res       Date:  2019-06

2.  Exercise-based cardiac rehabilitation for adults with heart failure.

Authors:  Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-01-29

3.  Correlation between exercise, personal income level and health-related quality of life in patients with newly diagnosed stable angina.

Authors:  Yi Wang; Lei Huang; Lai-Xin Zhou
Journal:  Mil Med Res       Date:  2019-11-25

4.  Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.

Authors:  Leonardo De Luca; Pier Luigi Temporelli; Donata Lucci; Furio Colivicchi; Paolo Calabrò; Carmine Riccio; Antonio Amico; Franco Mascia; Emanuele Proia; Andrea Di Lenarda; Michele Massimo Gulizia
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.